Shelf life (days): 1460.0
Formulation: A solid
Formal Name: (2S,4S)-4-cyclohexyl-1-(2-((R)-((S)-2-methyl-1-(propionyloxy)propoxy)(4-(phenyl-d5)butyl-4,4-d2)phosphoryl)acetyl)pyrrolidine-2-carboxylate, monosodium salt
Purity: ≥99% deuterated forms (d1-d7)
Formula Markup: C30H38D7NO7P / Na
Formula Weight: 592.686791
CAS Number: 1217819-83-4
Notes: Fosinopril-d7 is intended for use as an internal standard for the quantification of fosinopril (Item No. 21899) by GC- or LC-MS. Fosinopril is a prodrug form of the angiotensin-converting enzyme (ACE) inhibitor fosinoprilat.{39303} Oral administration of fosinopril inhibits angiotensin I-induced pressor responses in normotensive rats, dogs, and monkeys when administered at doses of 15, 15, and 10 µmol/kg, respectively. Fosinopril (2.5 mg/kg) reduces fractional shortening and decreases left ventricular size in a porcine model of congestive heart failure.{39770} Formulations containing fosinopril have been used in the treatment of hypertension and congestive heart failure.
Deutsch
English
